China Pharma Holdings
CPHI
7 hedge funds and large institutions have $424K invested in China Pharma Holdings in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
39% less capital invested
Capital invested by funds: $695K → $424K (-$271K)
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$39.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.6K |
| 3 |
Two Sigma Advisers
New York
|
+$9.55K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$131K |
| 2 |
HF
HRT Financial
New York
|
-$120K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11K |
CPHI Hedge Fund Activity: Q4 2021 in Review
7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2021, worth a combined $424K — down 39% from $695K a quarter earlier.
Fund positioning in CPHI was balanced in Q4 2021: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, adding an estimated $39.6K. The largest seller was Renaissance Technologies, cutting an estimated $131K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $424K of China Pharma Holdings stock for Q4 2021, down 39% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q4 2021 and 2 closed out, a net change of 0 holders.
- The largest China Pharma Holdings buyer in Q4 2021 was Virtu Financial, an estimated $39.6K added.
- The largest China Pharma Holdings seller in Q4 2021 was Renaissance Technologies, an estimated $131K sold.
Based on aggregated 13F filings for Q4 2021.